Certainly also drugs that interact with DNA damage and repair. PARP inhibitors have a very fixed now role in how we take care ...

Ovarian cancer can be a difficult-to-detect disease early on because its symptoms often are vague and easily mistaken. Here ...

At 92, Miriam Feder has found yet another purpose in life. The Brooklyn-born Eldorado resident has devoted herself to plenty ...

New research shows that blocking the CXCL12/CXCR4 signaling axis in ovarian cancer cells produces a paradoxical biphasic ...

The disease is diagnosed approximately 22,000 times every year in the U.S. with more than 12,000 deaths expected in 2026.

You're absolutely correct. The more recent approvals have certainly been for mirvetuximab [soravtansine] for our patients ...

Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine ...

Contrary to popular belief, the postmenopausal ovary is not defunct. In a new study of ovaries from 28 women, scientists at ...

BMC Cancer has retracted a 2021 study on LINC00852 and ovarian cancer after editors found duplicated images across multiple ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Jose Conejo-Garcia, MD, PhD, inventor ...

Niharika’s story Niharika, * a 58-year-old teacher who lives in North Carolina, had been experiencing bloating, abdominal ...

A 54-year-old woman found out she has ovarian cancer after persistent abdominal pain forced her to seek removal of her ...